skip to Main Content

SPEAKERS

SAMPLE OF KEYNOTE SPEAKERS AND THEIR CASE STUDIES

Luigi
PETILLO

Clinical Information Science Director

CASE STUDY / DAY 1

The New Era of Virtual Trials and Real-World Evidence: The Impact on Drug Development

Science has produced so much data in the last decades that nowadays, the difficulty is to be able to identify useful key information. The evolution of technologies and the speed of elaboration have finally made the handling of an enormous quantity of data more affordable. Nevertheless, new technologies have also changed people’s lives and habits.
We will try to understand what is the real impact of these changes on drug development and management of clinical trials: Opportunity or just an increase of difficulties?

  • Why has the era of virtual trial arrived?
  • Sharing of information and the need of using real-world evidence data
  • From virtual data to real-world data and vice versa
  • New technologies are a real opportunity or an increase of management difficulty?
  • Benefit/cost analysis of virtual trials

CASE STUDY / DAY 1

What Does a Patient-Centred Protocol Look Like?

Why is it so difficult to get a patient for a trial? And once recruited, why is it so difficult to keep the patient in the trial and on the study drug? Let us look at what discourages patients to get into, and remain in a trial. And with that in mind, what does an ideal patient-centred protocol look like? Are patient-centricity and regulatory requirements compatible?

  • The struggle of getting a patient interested in a trial
  • Keeping the patient in the trial and on the study drug: Difficulties connected with that
  • What discourages patients upfront, and while in the study?
  • What does the ideal patient-centred protocol look like?

Maarten
BOOMSMA

Clinical Study Director

This year Summit will host speakers from the world’s leading companies.
See sample of key note speakers.

Luigi
PETILLO

Clinical Information Science Director

Oleksandr
GORBENKO

Global Patient Centricity Director

Ekkehard
BROCKSTEDT

Head of Team Outsourced Trials, Corp. Div. Medicine

Ida
KLØVGAARD

Virtual Clinical Trial Manager

Claus
GOEBEL

Head Country Clinical Operations Germany & Switzerland

Maarten
BOOMSMA

Clinical Study Director

CASE STUDY / DAY 2

Platform Trials – A New Way Forward?

Platform trials investigate multiple therapies simultaneously. By sharing and control subjects, time and costs of trials could be reduced by up to 50% – depending on certain preconditions – making platform trials one of the most promising innovations in modern clinical trial design.

  • Introduction to platform trials: 1 disease/ X compounds
  • Key benefits vs. key challenges
  • Where and when to use it?
  • What do we need to run them successfully?

Ekkehard
BROCKSTEDT

Head of Team Outsourced Trials, Corp. Div. Medicine

Claus
GOEBEL

Head Country Clinical Operations Germany & Switzerland

CASE STUDY / DAY 2

Shared Information Platform (SIP) – A New Way of Customer-Centric Study Management

The Shared Investigator Platform (SIP) will be presented with the advantages for both sponsors and sites. SIP is a worldwide cloud-based internet portal (run by Cognizant) with the goal of making the documentation effortless and the exchange of information for centres and sponsors in clinical studies more efficient.

  • Background TransCelerate and Cognizant
  • Introduction to SIP – How does it work?
  • Advantages for sponsors
  • Advantages to sites
  • Current usage worldwide
FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

14th Annual Optimising Clinical Trials Summit: SITE SELECTION, FEASIBILITY & PATIENT RECRUITMENT
TIME IS RUNNING OUT! DON’T RISK MISSING IT
Back To Top

RELATED EVENTS

2nd Annual Global Medical Affairs Summit
7th Annual Risk Management and Pharmacovigilance Summit